Hepatorenal syndrome, acute tubular necrosis, and pneumonia may increase the need for renal replacement therapy in patients with cirrhosis and acute kidney injury.

Compared to the general population, individuals with incident hospital-based cannabis use disorder care have an increased risk of death.

Colorectal cancer was found to be the most common malignancy and cause of death among patients with classic familial adenomatous polyposis.

The FDA has approved Gvoke VialDx (glucagon) for IV use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the GI tract.

Colorectal cancer is tied to an increased risk for cardiovascular mortality, especially in individuals younger than 50 years.

The National Institutes of Health will no longer fund new research on how climate change affects people’s health.

The US Centers for Disease Control and Prevention is facing major changes, with five senior leaders stepping down.

Dozens of research projects focused on LGBTQ health have been canceled by the US government, alarming scientists.

In patients with metabolic dysfunction-associated steatotic liver disease, there is increased risk for heart failure with preserved ejection fraction.

Results were announced from a trial evaluating durvalumab with FLOT chemo as perioperative treatment for resectable early stage gastric/GEJ cancers.

In a US retrospective study of data on veterans with compensated cirrhosis, more than half progressed to complications after approximately 5 years.

An international longitudinal study found significantly increased mortality rates in patients with nonceliac enteropathies vs the general population.